TRANSPOSON THERAPEUTICS, INC.

Profile

Company Names

TRANSPOSON THERAPEUTICS, INC.

Addresses

4660 LA JOLLA VILLAGE DRIVE, SUITES 100 + 200, SAN DIEGO, CA 92122

2765 SAND HILL ROAD, C/O CANAAN PARTNERS, MENLO PARK, CA 94025

285 RIVERSIDE AVENUE, SUITE 250, WESTPORT, CT 06880

Phone Numbers

(858) 535-4821
9494229676
(949) 422-9676

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$59,121,723.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-07-10 
$4,679,395.00 
$20,000,000.00 
$15,320,605.00 
Debt 
3
2022-12-20 
$5,005,000.00 
$20,020,000.00 
$15,015,000.00 
Equity 
2
2020-11-25 
$45,187,328.00 
$45,187,328.00 
$0.00 
Equity 
1
2020-04-21 
$4,250,000.00 
$6,500,000.00 
$2,250,000.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRENT 
 
AHRENS 
DIRECTOR
COAXIA INC   |  COAPT SYSTEMS INC   |  ENDOGASTRIC SOLUTIONS INC   |  KALIDEX PHARMACEUTICALS, INC.   |  SEMNUR PHARMACEUTICALS, INC.   |  SPINIFEX PHARMACEUTICALS INC   |  RELIEVANT MEDSYSTEMS INC   |  MINIMALLY INVASIVE DEVICES INC.   |  UNCHAINED LABS   |  NEXCIDA THERAPEUTICS, INC.   |  TRANSPOSON THERAPEUTICS, INC.   |  RELIEVANT MEDSYSTEMS, INC.
WILLIAM 
 
HARRINGTON, MD, MBA 
DIRECTOR
TRANSPOSON THERAPEUTICS, INC.
DANIEL 
 
HETU, MD, MBA 
DIRECTOR
TRANSPOSON THERAPEUTICS, INC.
KEITH 
A. 
KATKIN 
DIRECTOR
CARBYLAN THERAPEUTICS, INC.   |  NOVUS THERAPEUTICS, INC.   |  TRANSPOSON THERAPEUTICS, INC.
JOHN 
 
PACIFICO 
DIRECTOR
ORTHOCON INC   |  TRANSPOSON THERAPEUTICS, INC.
DENNIS 
 
PODLESAK 
DIRECTOR, EXECUTIVE OFFICER
CORTHERA INC   |  REGADO BIOSCIENCES INC   |  SYNDAX PHARMACEUTICALS INC   |  ADYNXX INC   |  KALIDEX PHARMACEUTICALS, INC.   |  RIGHTCARE SOLUTIONS, INC.   |  ADYNXX, INC.   |  ADASTRA PHARMACEUTICALS, INC.   |  EXALYS THERAPEUTICS, INC.   |  TRANSPOSON THERAPEUTICS, INC.
LYNNE 
 
ROLLINS 
EXECUTIVE OFFICER
HELIXIS INC   |  SONEXA THERAPEUTICS INC   |  NANOTHERA CORP   |  ABREXA PHARMACEUTICALS, INC.   |  SONEXA THERAPEUTICS, INC   |  BIONANO GENOMICS, INC   |  WIRELESS DIAGNOSTIC SYSTEMS, INC.   |  TRETHERA CORP   |  GENE SCIENCES, INC.   |  CHROMACODE, INC.   |  EXALYS THERAPEUTICS, INC.   |  TRANSPOSON THERAPEUTICS, INC.
LYNNE 
R. 
ROLLINS 
EXECUTIVE OFFICER
INSPIRATION BIOPHARMACEUTICALS INC   |  ADASTRA PHARMACEUTICALS, INC.   |  TRANSPOSON THERAPEUTICS, INC.
BRIAN 
TAYLOR 
SLINGSBY, MD, PHD, MPH 
DIRECTOR
TRANSPOSON THERAPEUTICS, INC.
ECKARD 
 
WEBER, M.D. 
EXECUTIVE OFFICER, DIRECTOR
TRAGARA PHARMACEUTICALS INC   |  SONEXA THERAPEUTICS INC   |  NANOTHERA CORP   |  ABREXA PHARMACEUTICALS, INC.   |  OCERA THERAPEUTICS INC   |  SONEXA THERAPEUTICS, INC   |  RIGHTCARE SOLUTIONS, INC.   |  EXALYS THERAPEUTICS, INC.   |  TRANSPOSON THERAPEUTICS, INC.
ECKARD 
 
WEBER, MD 
EXECUTIVE OFFICER, DIRECTOR
TRANSPOSON THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-07-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2024-07-10 
2023-01-12
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-20 
2022-12-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-20 
2020-12-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-25 
2020-05-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2020-04-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#